Search results for "Highlights"
Surgical, drug treatments have similar outcomes in patients with vitreous hemorrhage from proliferative diabetic retinopathy
A randomized trial found equivalent improvements in visual acuity at two years with either therapy but identified some differences in outcomes that could help patients and clinicians choose a treatment method.
https://diabetes.acponline.org/archives/2021/01/08/2.htm
8 Jan 2021
Intermittent fasting may be effective weight loss strategy in patients with type 2 diabetes
A systematic review and meta-analysis of seven studies found that intermittent fasting induced a greater decrease in body weight compared to regular diet but was not associated with any greater reduction in HbA1c levels.
https://diabetes.acponline.org/archives/2021/01/08/1.htm
8 Jan 2021
Patients with type 2 diabetes and all risk factors controlled still have increased CVD risk
Risk factor control was more strongly associated with mortality risk among patients with cardiorenal disease than those without, according to a retrospective British study.
https://diabetes.acponline.org/archives/2020/12/11/3.htm
11 Dec 2020
Balanced crystalloids may be preferred for acute resolution of diabetic ketoacidosis
A small subgroup analysis of two randomized trials found that median time to resolution of diabetic ketoacidosis was 13 hours in patients who received balanced crystalloids versus nearly 17 hours in those who received saline.
https://diabetes.acponline.org/archives/2020/12/11/2.htm
11 Dec 2020
Diabetes remission after bariatric surgery may be more likely in younger patients with shorter disease duration
Long-term results from the Longitudinal Assessment of Bariatric Surgery suggested that diabetes remission is more likely after bariatric surgery performed soon after diagnosis, when diabetes medication burden is low and beta-cell function is preserved, study authors noted.
https://diabetes.acponline.org/archives/2020/12/11/1.htm
11 Dec 2020
Recent KDIGO guideline focused on patients with diabetes and kidney disease
A new summary of the guideline from Kidney Disease: Improving Global Outcomes (KDIGO) highlights important points for clinicians, including recommendations about prescribing of diabetes medications.
https://diabetes.acponline.org/archives/2020/11/13/7.htm
13 Nov 2020
One-time serum C-peptide testing detected patients misclassified as having type 1 diabetes
In a recent study, a serum C-peptide testing program resulted in reclassification of the cause of diabetes in about 7% of the cohort tested at one diabetes center in Scotland. Reclassification was most likely in those diagnosed at age 30 years or older.
https://diabetes.acponline.org/archives/2020/11/13/2.htm
13 Nov 2020
In type 2 diabetes patients, lower LDL cholesterol levels after PCI associated with better outcomes
A pooled analysis of three randomized clinical trials found reductions in major adverse cardiac or cerebrovascular events after percutaneous coronary intervention (PCI) at 3.9-year follow-up only in patients with low-density lipoprotein (LDL) cholesterol levels below 70 mg/dL at one year.
https://diabetes.acponline.org/archives/2020/11/13/3.htm
13 Nov 2020
New guideline from Endocrine Society offers guidance on lipid management
The guideline includes recommendations on the use of statins and lipid testing in type 1 and 2 diabetes, as well as other endocrine-related diseases and conditions.
https://diabetes.acponline.org/archives/2020/11/13/1.htm
13 Nov 2020
AHA scientific statement reviews research on drugs for diabetes and chronic kidney disease
The advent of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists could reduce cardiovascular adverse events and progression to end-stage kidney disease, the American Heart Association (AHA) scientific statement noted.
https://diabetes.acponline.org/archives/2020/10/09/2.htm
9 Oct 2020